SecBot SecBot

PRNAF

ALTERITY THERAPEUTICS LTD
OTC· Pharmaceutical Preparations· Inc. C3· CIK 0001131343 Biotech & Drug Discovery
$0.2500 +0.00 (+0.00%)
Oct 27 4:00 PM ET · prev $0.2500
1 year
+3471.4%
from $0.007000 · Oct 28
30 days
−37.5%
from $0.4000
52-week range
$0.000200–0.5501
−55% from high · low Mar 23
Avg volume 20D
125
Oct 12 spike 2.5K
Short interest
1.7K
−37.3%
Filing reports
14
analyzed by SecBot
SecBot read BULLISH 5 reports · latest
Balance 0 bearish · 1 bullish · 4 neutral oldest → newest, height = score
Avg score ·High conf. 5/5
Strongest BULLISH Alterity Therapeutics announced successful alignment with the FDA on the pivotal Phase 3 program for ATH434…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • Short sellersCOVERING

    Short interest −37.3% to 1.7K shares.

  • TrendDOWNTREND

    30% below its 50-day average.

Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Jun 9, 2026 SEC
Alterity Therapeutics announced successful alignment with the FDA on the pivotal Phase 3 program for ATH434 in…
6-K — Impact 7/10
Jun 4, 2026 SEC
Alterity Therapeutics filed a 6-K confirming a 1-for-50 reverse share consolidation, effective June 3, 2026, with…
6-K — Impact 3/10
Jun 3, 2026 SEC
Alterity Therapeutics filed a Form 6-K on June 3, 2026, solely to report a change in its registered office address to…
6-K — Impact 1/10

Earnings setup

Estimates
PeriodEPS est.Range30D rev.Revenue
Current Q———$0.00
Next Q———$0.00
Current FY———$1.1M
Next FY———$2.0M

Short side

FINRA· Sep 30, 2026
1,694
shares short
-37.3%
vs prior settlement

SecBot reports

14 filings · 4 bullish · 0 bearish · 10 neutral
All PRNAF filing & press-release reports (14)